As a consequence, increased expression of MMP2 and MMP9 have been associated with a more aggressive phenotype and poor prognosis in several solid tumors including breast cancer [24], ovarian carcinoma [25], head and neck squamous cell carcinoma [26] and gastric cancer [20]. Here, MMP9 is linked to head and neck squamous cell carcinoma.